Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults
Most Cited Paper
in Mosquito-borne diseases and control
18 Months Post-Publication
Class of 2026
“Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults”
A research intelligence initiative by Pepkio
pri.pepkio.com/top-papers/mosquito-borne-diseases-and-control/2026/
Topics
Butantan-Dengue Vaccine · live attenuated tetravalent vaccine · Single-dose vaccine · vaccine efficacy · Virologically confirmed dengue · dengue serostatus at baseline · DENV-1 · DENV-2 · DENV-3 · DENV-4 · dengue viral serotype · Seronegative participants · Seropositive participants · solicited systemic adverse events · phase 3 double-blind trial · 2-year follow-up · age-stratified efficacy · serotype-specific efficacy
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Mosquito-borne diseases and control Papers, Class of 2026. https://pri.pepkio.com/top-papers/mosquito-borne-diseases-and-control/2026. Accessed 2026-07-17. Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459